{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T04:26:23Z","timestamp":1791779183368,"version":"4.3.4"},"reference-count":118,"publisher":"Georg Thieme Verlag KG","issue":"09","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Thromb Haemost"],"published-print":{"date-parts":[[2025,9]]},"abstract":"<jats:p>Many patients with atrial fibrillation (AF) who are in need of stroke prevention are not treated with oral anticoagulation or discontinue treatment shortly after its initiation. Despite the availability of direct oral anticoagulants (DOACs), such undertreatment has improved somewhat but is still evident. This is due to continued risks of bleeding events or ischemic strokes while on DOAC, poor treatment compliance, or aversion to anticoagulant therapy. Because of significant improvements in procedural safety over the years left atrial appendage closure (LAAC), using a catheter-based, device implantation approach, is increasingly favored for the prevention of thromboembolic events in AF patients who cannot have long-term oral anticoagulation. This article is an executive summary of a practical guide recently published by an international expert consensus group, which introduces the LAAC devices and briefly explains the implantation technique. The indications and device follow-up are more comprehensively described. This practical guide, aligned with published guideline\/guidance, is aimed at those non-implanting physicians who may need to refer patients for consideration of LAAC.<\/jats:p>","DOI":"10.1055\/a-2469-4896","type":"journal-article","created":{"date-parts":[[2024,12,10]],"date-time":"2024-12-10T19:18:52Z","timestamp":1733858332000},"page":"825-846","source":"Crossref","is-referenced-by-count":12,"title":["An International Consensus Practical Guide on Left Atrial Appendage Closure for the Non-implanting Physician: Executive Summary"],"prefix":"10.1055","volume":"125","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6285-6902","authenticated-orcid":false,"given":"Tatjana","family":"Potpara","sequence":"additional","affiliation":[{"name":"Medical Faculty, University of Belgrade, University Clinical Centre of Serbia, Belgrade, Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1134-7099","authenticated-orcid":false,"given":"Marek","family":"Grygier","sequence":"additional","affiliation":[{"name":"1st Department of Cardiology, Poznan University School of Medical Sciences, Poznan, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6389-5054","authenticated-orcid":false,"given":"Karl Georg","family":"Haeusler","sequence":"additional","affiliation":[{"name":"Department of Neurology, Universit\u00e4tsklinikum W\u00fcrzburg (UKW), W\u00fcrzburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6473-2900","authenticated-orcid":false,"given":"Jens Erik","family":"Nielsen-Kudsk","sequence":"additional","affiliation":[{"name":"Aarhus University Hospital, Aarhus, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5244-0556","authenticated-orcid":false,"given":"Sergio","family":"Berti","sequence":"additional","affiliation":[{"name":"Ospedale del Cuore, Fondazione CNR Regione Toscana G. Monasterio, Pisa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4699-4149","authenticated-orcid":false,"given":"Simonetta","family":"Genovesi","sequence":"additional","affiliation":[{"name":"School of Medicine and Surgery, Nephrology Clinic, Monza, Italy and Istituto Auxologico Italiano, University of Milano-Bicocca, IRCCS, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7227-3428","authenticated-orcid":false,"given":"Eloi","family":"Marijon","sequence":"additional","affiliation":[{"name":"Division of Cardiology, European Georges Pompidou Hospital, AP-HP, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1280-7042","authenticated-orcid":false,"given":"Serge","family":"Boveda","sequence":"additional","affiliation":[{"name":"Cardiology, Heart Rhythm Management Department, Clinique Pasteur, Toulouse, France"},{"name":"Brussels University VUB, Brussels, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6968-2191","authenticated-orcid":false,"given":"Apostolos","family":"Tzikas","sequence":"additional","affiliation":[{"name":"European Interbalkan Medical Centre, Aristotle University of Thessaloniki, Ippokrateio Hospital of Thessaloniki, Thessaloniki, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9820-4815","authenticated-orcid":false,"given":"Giuseppe","family":"Boriani","sequence":"additional","affiliation":[{"name":"Cardiology Division, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Policlinico di Modena, Modena, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4591-4220","authenticated-orcid":false,"given":"Lucas V. A.","family":"Boersma","sequence":"additional","affiliation":[{"name":"Cardiology Department, St. Antonius Hospital Nieuwegein\/Amsterdam University Medical Centers, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8500-8313","authenticated-orcid":false,"given":"Claudio","family":"Tondo","sequence":"additional","affiliation":[{"name":"Department of Clinical Electrophysiology and Cardiac Pacing, Department of Biomedical, Surgical and Dental Sciences, Centro Cardiologico Monzino, IRCCS, University of Milan, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1424-114X","authenticated-orcid":false,"given":"Tom De","family":"Potter","sequence":"additional","affiliation":[{"name":"Cardiovascular Center Aalst, OLV Hospital, Aalst, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7566-1626","authenticated-orcid":false,"given":"Gregory Y. H.","family":"Lip","sequence":"additional","affiliation":[{"name":"Liverpool Centre for Cardiovascular Science at University of Liverpool, Liverpool John Moores University and Liverpool Heart and Chest Hospital, Liverpool, United Kingdom"},{"name":"Department of Clinical Medicine, Danish Center for Health Services Research, Aalborg University, Aalborg, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7170-9509","authenticated-orcid":false,"given":"Renate B.","family":"Schnabel","sequence":"additional","affiliation":[{"name":"Department of Cardiology, University Heart and Vascular Centre Hamburg, Hamburg, Germany"},{"name":"German Centre for Cardiovascular Research (DZHK), Partner Site Hamburg\/Kiel\/L\u00fcbeck, Hamburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6192-1741","authenticated-orcid":false,"given":"Rupert","family":"Bauersachs","sequence":"additional","affiliation":[{"name":"Cardioangiology Center Bethanien CCB, Frankfurt, Germany; Center for Vascular Research, Munich, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7261-6520","authenticated-orcid":false,"given":"Marco","family":"Senzolo","sequence":"additional","affiliation":[{"name":"Department of Surgery, Oncology and Gastroenterology, University Hospital of Padua, Padua, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8152-5471","authenticated-orcid":false,"given":"Carlo","family":"Basile","sequence":"additional","affiliation":[{"name":"Division of Nephrology, EuDial Working Group of the European Renal Association, Miull General Hospital, Acquaviva delle Fonti, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3981-6325","authenticated-orcid":false,"given":"Stefano","family":"Bianchi","sequence":"additional","affiliation":[{"name":"Nephrology and Dialysis Unit, Italian Society of Nephrology, ASL Toscana NordOvest, Livorno, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0482-4448","authenticated-orcid":false,"given":"Pavel","family":"Osmancik","sequence":"additional","affiliation":[{"name":"Department of Cardiology, University Hospital Kralovske Vinohrady, Charles University, Prague, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5347-9906","authenticated-orcid":false,"given":"Boris","family":"Schmidt","sequence":"additional","affiliation":[{"name":"Cardioangiologisches Centrum Bethanien, Agaplesion Markus Krankenhaus, Frankfurt, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0214-3203","authenticated-orcid":false,"given":"Ulf","family":"Landmesser","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Angiology, and Intensive Care Medicine, Deutsches Herzzentrum Charit\u00e9, Charit\u00e9 University Medicine Berlin, Friede Springer Cardiovascular Prevention Center @Charit\u00e9, Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7598-708X","authenticated-orcid":false,"given":"Wolfram","family":"Doehner","sequence":"additional","affiliation":[{"name":"Berlin Institute of Health-Center for Regenerative Therapies, Berlin, Germany, Deutsches Herzzentrum der Charit\u00e9, Campus Virchow Klinikum, Berlin, Germany"},{"name":"German Centre for Cardiovascular Research (DZHK)- Partner Site Berlin, Charit\u00e9 Universit\u00e4tsmedizin Berlin, Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0132-0773","authenticated-orcid":false,"given":"Gerhard","family":"Hindricks","sequence":"additional","affiliation":[{"name":"German Heart Center Charite, Campus Mitte, Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2007-888X","authenticated-orcid":false,"given":"Jan","family":"Kovac","sequence":"additional","affiliation":[{"name":"Leicester NIHR BRU, University of Leicester, Glenfield Hospital, Leicester, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2536-2871","authenticated-orcid":false,"given":"A. John","family":"Camm","sequence":"additional","affiliation":[{"name":"St. George's University of London, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"194","published-online":{"date-parts":[[2024,12,10]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"100786","DOI":"10.1016\/j.lanepe.2023.100786","article-title":"Atrial fibrillation: epidemiology, screening and digital health","volume":"37","author":"D Linz","year":"2024","journal-title":"Lancet Reg Health Eur"},{"issue":"35","key":"ref2","doi-asserted-by":"crossref","first-page":"2746","DOI":"10.1093\/eurheartj\/eht280","article-title":"Projections on the number of individuals with atrial fibrillation in the European Union, from 2000 to 2060","volume":"34","author":"B P Krijthe","year":"2013","journal-title":"Eur Heart J"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"100797","DOI":"10.1016\/j.lanepe.2023.100797","article-title":"Atrial fibrillation: stroke prevention","volume":"37","author":"T F Chao","year":"2024","journal-title":"Lancet Reg Health Eur"},{"issue":"12","key":"ref4","doi-asserted-by":"crossref","first-page":"857","DOI":"10.7326\/0003-4819-146-12-200706190-00007","article-title":"Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation","volume":"146","author":"R G Hart","year":"2007","journal-title":"Ann Intern Med"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/S0140-6736(13)62343-0","article-title":"Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials","volume":"383","author":"C T Ruff","year":"2014","journal-title":"Lancet"},{"issue":"23","key":"ref6","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1001\/jama.2021.21222","article-title":"Association of rivaroxaban vs apixaban with major ischemic or hemorrhagic events in patients with atrial fibrillation","volume":"326","author":"W A Ray","year":"2021","journal-title":"JAMA"},{"issue":"12","key":"ref7","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1055\/s-0042-1756355","article-title":"Clinical complexity domains, anticoagulation, and outcomes in patients with atrial fibrillation: a report from the GLORIA-AF Registry Phase II and III","volume":"122","author":"G F Romiti","year":"2022","journal-title":"Thromb Haemost"},{"issue":"20","key":"ref8","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1161\/CIRCULATIONAHA.112.000491","article-title":"Causes of death and influencing factors in patients with atrial fibrillation: a competing-risk analysis from the randomized evaluation of long-term anticoagulant therapy study","volume":"128","author":"E Marijon","year":"2013","journal-title":"Circulation"},{"issue":"04","key":"ref9","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1161\/CIRCULATIONAHA.121.056355","article-title":"Direct oral anticoagulants versus warfarin in patients with atrial fibrillation: patient-level network meta-analyses of randomized clinical trials with interaction testing by age and sex","volume":"145","author":"A P Carnicelli","year":"2022","journal-title":"Circulation"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.thromres.2019.01.020","article-title":"Resumption of anticoagulant therapy after anticoagulant-related gastrointestinal bleeding: a systematic review and meta-analysis","volume":"175","author":"D Little","year":"2019","journal-title":"Thromb Res"},{"issue":"09","key":"ref11","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1055\/a-1789-4824","article-title":"Managing uncertainty: physicians' decision making for stroke prevention for patients with atrial fibrillation and intracerebral hemorrhage","volume":"122","author":"E Ivany","year":"2022","journal-title":"Thromb Haemost"},{"issue":"11","key":"ref12","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1055\/s-0044-1786028","article-title":"Clinical outcomes of patients with atrial fibrillation who survived from bleeding event: the results from COOL-AF Thailand registry","volume":"124","author":"A Winijkul","year":"2024","journal-title":"Thromb Haemost"},{"issue":"01","key":"ref13","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1093\/europace\/euz212","article-title":"The left atrial appendage in humans: structure, physiology, and pathogenesis","volume":"22","author":"N Karim","year":"2020","journal-title":"Europace"},{"issue":"04","key":"ref14","doi-asserted-by":"crossref","first-page":"euae035","DOI":"10.1093\/europace\/euae035","article-title":"Practical guide on left atrial appendage closure for the non-implanting physician: an international consensus paper","volume":"26","author":"T Potpara","year":"2024","journal-title":"Europace"},{"issue":"24","key":"ref15","doi-asserted-by":"crossref","first-page":"2964","DOI":"10.1016\/j.jacc.2017.10.021","article-title":"5-year outcomes after left atrial appendage closure: from the PREVAIL and PROTECT AF trials","volume":"70","author":"V Y Reddy","year":"2017","journal-title":"J Am Coll Cardiol"},{"issue":"01","key":"ref16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jacc.2021.10.023","article-title":"4-year outcomes after left atrial appendage closure versus nonwarfarin oral anticoagulation for atrial fibrillation","volume":"79","author":"P Osmancik","year":"2022","journal-title":"J Am Coll Cardiol"},{"issue":"23","key":"ref17","doi-asserted-by":"crossref","first-page":"2795","DOI":"10.1016\/j.jacc.2020.08.089","article-title":"Left atrial appendage closure versus oral anticoagulants in atrial fibrillation: a meta-analysis of randomized trials","volume":"76","author":"M K Turagam","year":"2020","journal-title":"J Am Coll Cardiol"},{"issue":"10","key":"ref19","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.4244\/EIJY15M01_06","article-title":"Left atrial appendage occlusion for stroke prevention in atrial fibrillation: multicentre experience with the AMPLATZER Cardiac Plug","volume":"11","author":"A Tzikas","year":"2016","journal-title":"EuroIntervention"},{"issue":"30","key":"ref20","doi-asserted-by":"crossref","first-page":"2894","DOI":"10.1093\/eurheartj\/ehaa169","article-title":"Left atrial appendage occlusion with the Amplatzer\u2122 Amulet\u2122 device: full results of the prospective global observational study","volume":"41","author":"D Hildick-Smith","year":"2020","journal-title":"Eur Heart J"},{"issue":"09","key":"ref21","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1016\/j.hrthm.2017.05.038","article-title":"Efficacy and safety of left atrial appendage closure with WATCHMAN in patients with or without contraindication to oral anticoagulation: 1-year follow-up outcome data of the EWOLUTION trial","volume":"14","author":"L V Boersma","year":"2017","journal-title":"Heart Rhythm"},{"issue":"13","key":"ref22","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1016\/j.jacc.2019.12.040","article-title":"The NCDR left atrial appendage occlusion registry","volume":"75","author":"J V Freeman","year":"2020","journal-title":"J Am Coll Cardiol"},{"issue":"07","key":"ref23","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.jcin.2022.02.009","article-title":"Clinical outcomes at 1 year following transcatheter left atrial appendage occlusion in the United States","volume":"15","author":"M J Price","year":"2022","journal-title":"JACC Cardiovasc Interv"},{"issue":"04","key":"ref24","doi-asserted-by":"crossref","first-page":"e026295","DOI":"10.1161\/JAHA.122.026295","article-title":"Two-year outcomes with a next-generation left atrial appendage device: final results of the PINNACLE FLX trial","volume":"12","author":"S K Doshi","year":"2023","journal-title":"J Am Heart Assoc"},{"issue":"22","key":"ref26","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1056\/NEJMoa2101897","article-title":"Left atrial appendage occlusion during cardiac surgery to prevent stroke","volume":"384","author":"R P Whitlock","year":"2021","journal-title":"N Engl J Med"},{"issue":"16","key":"ref27","doi-asserted-by":"crossref","first-page":"e034815","DOI":"10.1161\/JAHA.124.034815","article-title":"Left atrial appendage closure compared with oral anticoagulants for patients with atrial fibrillation: a systematic review and network meta-analysis","volume":"13","author":"A Oliva","year":"2024","journal-title":"J Am Heart Assoc"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.ahj.2022.05.001","article-title":"COMPARE LAAO: rationale and design of the randomized controlled trial \u201cCOMPARing Effectiveness and safety of Left Atrial Appendage Occlusion to standard of care for atrial fibrillation patients at high stroke risk and ineligible to use oral anticoagulation therapy.\u201d","volume":"250","author":"M Huijboom","year":"2022","journal-title":"Am Heart J"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.ahj.2022.05.003","article-title":"Comparison of anticoagulation with left atrial appendage closure after atrial fibrillation ablation: rationale and design of the OPTION randomized trial","volume":"251","author":"O M Wazni","year":"2022","journal-title":"Am Heart J"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.ahj.2023.05.022","article-title":"Rationale and design of a randomized study comparing the Watchman FLX device to DOACs in patients with atrial fibrillation","volume":"264","author":"S Kar","year":"2023","journal-title":"Am Heart J"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.ahj.2021.08.020","article-title":"Left atrial appendage occlusion vs novel oral anticoagulation for stroke prevention in atrial fibrillation: rationale and design of the multicenter randomized occlusion-AF trial","volume":"243","author":"K Korsholm","year":"2022","journal-title":"Am Heart J"},{"issue":"03","key":"ref46","doi-asserted-by":"crossref","first-page":"371","DOI":"10.4244\/EIJ-D-17-00201","article-title":"Left atrial appendage occlusion versus standard medical care in patients with atrial fibrillation and intracerebral haemorrhage: a propensity score-matched follow-up study","volume":"13","author":"J E Nielsen-Kudsk","year":"2017","journal-title":"EuroIntervention"},{"issue":"01","key":"ref47","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jcin.2020.09.051","article-title":"Clinical outcomes associated with left atrial appendage occlusion versus direct oral anticoagulation in atrial fibrillation","volume":"14","author":"J E Nielsen-Kudsk","year":"2021","journal-title":"JACC Cardiovasc Interv"},{"issue":"01","key":"ref48","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1055\/s-0041-1739411","article-title":"2021 focused update consensus guidelines of the Asia Pacific Heart Rhythm Society on stroke prevention in atrial fibrillation: executive summary","volume":"122","author":"T F Chao","year":"2022","journal-title":"Thromb Haemost"},{"issue":"10","key":"ref49","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1055\/a-2325-5923","article-title":"2024 Chinese expert consensus guidelines on the diagnosis and treatment of atrial fibrillation in the elderly, endorsed by Geriatric Society of Chinese Medical Association (Cardiovascular Group) and Chinese Society of Geriatric Health Medicine (Cardiovascular Branch): executive summary","volume":"124","author":"Y Wang","year":"2024","journal-title":"Thromb Haemost"},{"issue":"01","key":"ref50","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.jacc.2023.08.017","article-title":"2023 ACC\/AHA\/ACCP\/HRS guideline for the diagnosis and management of atrial fibrillation: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"83","author":"J A Joglar","year":"2024","journal-title":"J Am Coll Cardiol"},{"issue":"36","key":"ref51","doi-asserted-by":"crossref","first-page":"3314","DOI":"10.1093\/eurheartj\/ehae176","article-title":"2024 ESC guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)","volume":"45","author":"I C Van Gelder","year":"2024","journal-title":"Eur Heart J"},{"issue":"03","key":"ref53","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1055\/a-1515-9630","article-title":"Adherence to the \u201cAtrial Fibrillation Better Care\u201d pathway in patients with atrial fibrillation: impact on clinical outcomes\u2014a systematic review and meta-analysis of 285,000 patients","volume":"122","author":"G F Romiti","year":"2022","journal-title":"Thromb Haemost"},{"issue":"11","key":"ref54","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1093\/europace\/euac082","article-title":"Evaluation of the atrial fibrillation better care pathway in the ENGAGE AF-TIMI 48 trial","volume":"24","author":"S M Patel","year":"2022","journal-title":"Europace"},{"issue":"10","key":"ref55","doi-asserted-by":"crossref","first-page":"e014932","DOI":"10.1161\/JAHA.119.014932","article-title":"Comprehensive management with the ABC (Atrial Fibrillation Better Care) pathway in clinically complex patients with atrial fibrillation: a post hoc ancillary analysis from the AFFIRM trial","volume":"9","author":"M Proietti","year":"2020","journal-title":"J Am Heart Assoc"},{"issue":"06","key":"ref56","first-page":"e25567","article-title":"National yearly trend of utilization and procedural complication of the Watchman device in the United States","volume":"14","author":"B Shrestha","year":"2022","journal-title":"Cureus"},{"issue":"07","key":"ref57","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1093\/europace\/euz032","article-title":"EORP-AF Long-Term General Registry Investigators. Association between antithrombotic treatment and outcomes at 1-year follow-up in patients with atrial fibrillation: the EORP-AF General Long-Term Registry","volume":"21","author":"G Boriani","year":"2019","journal-title":"Europace"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"20432","DOI":"10.1038\/srep20432","article-title":"BALKAN-AF Investigators. Stroke prevention in atrial fibrillation and \u201creal world\u201d adherence to guidelines in the Balkan Region: the BALKAN-AF survey","volume":"6","author":"T S Potpara","year":"2016","journal-title":"Sci Rep"},{"issue":"S 02","key":"ref59","doi-asserted-by":"crossref","first-page":"ehac544.2137","DOI":"10.1093\/eurheartj\/ehac544.2137","article-title":"Trends in percutaneous left atrial appendage occlusion and 1-year mortality: a nationwide cohort study","volume":"43","author":"O Juhl Madsen","year":"2022","journal-title":"Eur Heart J"},{"issue":"05","key":"ref60","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/j.chest.2018.07.040","article-title":"Antithrombotic therapy for atrial fibrillation: CHEST guideline and expert panel report","volume":"154","author":"G YH Lip","year":"2018","journal-title":"Chest"},{"issue":"10","key":"ref61","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/j.hlc.2018.06.1043","article-title":"NHFA CSANZ Atrial Fibrillation Guideline Working Group. National Heart Foundation of Australia and the Cardiac Society of Australia and New Zealand: Australian clinical guidelines for the diagnosis and management of atrial fibrillation 2018","volume":"27","author":"D Brieger","year":"2018","journal-title":"Heart Lung Circ"},{"issue":"01","key":"ref62","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.jacc.2019.01.011","article-title":"2019 AHA\/ACC\/HRS focused update of the 2014 AHA\/ACC\/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society","volume":"74","author":"C T January","year":"2019","journal-title":"J Am Coll Cardiol"},{"issue":"05","key":"ref63","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1093\/eurheartj\/ehaa612","article-title":"ESC Scientific Document Group. 2020 ESC guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): the task force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC","volume":"42","author":"G Hindricks","year":"2021","journal-title":"Eur Heart J"},{"issue":"12","key":"ref64","first-page":"1847","article-title":"Members of the Secondary Panel. The 2020 Canadian Cardiovascular Society\/Canadian Heart Rhythm Society comprehensive guidelines for the management of atrial fibrillation","volume":"36","author":"J G Andrade","year":"2020","journal-title":"Can J Cardiol"},{"issue":"11","key":"ref65","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1016\/j.jcin.2023.01.011","article-title":"SCAI\/HRS expert consensus statement on transcatheter left atrial appendage closure","volume":"16","author":"J Saw","year":"2023","journal-title":"JACC Cardiovasc Interv"},{"issue":"13","key":"ref66","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.4244\/EIJY19M08_01","article-title":"EHRA\/EAPCI expert consensus statement on catheter-based left atrial appendage occlusion\u2014an update","volume":"15","author":"M Glikson","year":"2020","journal-title":"EuroIntervention"},{"issue":"01","key":"ref67","first-page":"4","article-title":"Percutaneous left atrial appendage occlusion: the Munich consensus document on definitions, endpoints, and data collection requirements for clinical studies","volume":"19","author":"A Tzikas","year":"2017","journal-title":"Europace"},{"issue":"07","key":"ref68","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1093\/europace\/euad204","article-title":"Diagnostic and therapeutic pathways for the malignant left atrial appendage: European Heart Rhythm Association physician survey","volume":"25","author":"A Anic","year":"2023","journal-title":"Europace"},{"issue":"05","key":"ref69","first-page":"25","article-title":"Leap or lag: left atrial appendage closure and guidelines","volume":"25","author":"A J Camm","year":"2023","journal-title":"Europace"},{"issue":"02","key":"ref70","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1093\/europace\/euz258","article-title":"EHRA\/EAPCI expert consensus statement on catheter-based left atrial appendage occlusion\u2014an update","volume":"22","author":"M Glikson","year":"2020","journal-title":"Europace"},{"issue":"20","key":"ref71","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1093\/eurheartj\/ehae198","article-title":"Ischaemic stroke in women with atrial fibrillation: temporal trends and clinical implications","volume":"45","author":"K Teppo","year":"2024","journal-title":"Eur Heart J"},{"issue":"01","key":"ref72","doi-asserted-by":"crossref","first-page":"6728","DOI":"10.1038\/s41467-024-51193-0","article-title":"Risk of stroke in male and female patients with atrial fibrillation in a nationwide cohort","volume":"15","author":"P B Nielsen","year":"2024","journal-title":"Nat Commun"},{"key":"ref73","doi-asserted-by":"crossref","first-page":"100967","DOI":"10.1016\/j.lanepe.2024.100967","article-title":"Comparing CHA2DS2-VA and CHA2DS2-VASc scores for stroke risk stratification in patients with atrial fibrillation: a temporal trends analysis from the retrospective Finnish AntiCoagulation in Atrial Fibrillation (FinACAF) cohort","volume":"43","author":"K Teppo","year":"2024","journal-title":"Lancet Reg Health Eur"},{"issue":"11","key":"ref74","doi-asserted-by":"crossref","first-page":"euae280","DOI":"10.1093\/europace\/euae280","article-title":"Refining the CHA2DS2VASc risk stratification scheme: shall we drop the sex category criterion?","volume":"26","author":"H Yoshimura","year":"2024","journal-title":"Europace"},{"issue":"06","key":"ref76","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1016\/j.hrthm.2016.03.024","article-title":"Is transesophageal echocardiogram mandatory in patients undergoing ablation of atrial fibrillation with uninterrupted novel oral anticoagulants? Results from a prospective multicenter registry","volume":"13","author":"L Di Biase","year":"2016","journal-title":"Heart Rhythm"},{"issue":"12","key":"ref77","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1016\/j.amjcard.2018.02.045","article-title":"Feasibility of left atrial appendage occlusion for left atrial appendage thrombus in patients with persistent atrial fibrillation","volume":"121","author":"O H Lee","year":"2018","journal-title":"Am J Cardiol"},{"issue":"03","key":"ref78","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.jcin.2019.08.054","article-title":"Expert recommendations on cardiac computed tomography for planning transcatheter left atrial appendage occlusion","volume":"13","author":"K Korsholm","year":"2020","journal-title":"JACC Cardiovasc Interv"},{"issue":"06","key":"ref79","first-page":"20200449","article-title":"A comparison of cardiac computed tomography, transesophageal and intracardiac echocardiography, and fluoroscopy for planning left atrial appendage closure","volume":"13","author":"P Osmancik","year":"2021","journal-title":"J Atr Fibrillation"},{"issue":"10","key":"ref80","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1111\/jce.13042","article-title":"Vascular complications during catheter ablation of cardiac arrhythmias: a comparison between vascular ultrasound guided access and conventional vascular access","volume":"27","author":"P S Sharma","year":"2016","journal-title":"J Cardiovasc Electrophysiol"},{"issue":"07","key":"ref81","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1093\/europace\/eux175","article-title":"Ultrasound-guided versus conventional femoral venipuncture for catheter ablation of atrial fibrillation: a multicentre randomized efficacy and safety trial (ULTRA-FAST trial)","volume":"20","author":"K Yamagata","year":"2018","journal-title":"Europace"},{"issue":"05","key":"ref82","first-page":"850","article-title":"Ultrasound-guided cannulation of the femoral vein in electrophysiological procedures: a systematic review and meta-analysis","volume":"19","author":"M Sobolev","year":"2017","journal-title":"Europace"},{"issue":"01","key":"ref83","first-page":"CD011447","article-title":"Ultrasound guidance versus anatomical landmarks for subclavian or femoral vein catheterization","volume":"1","author":"P Brass","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"issue":"02","key":"ref84","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/s10840-019-00683-z","article-title":"Ultrasound guidance for femoral venous access in electrophysiology procedures\u2014systematic review and meta-analysis","volume":"59","author":"P Kup\u00f3","year":"2020","journal-title":"J Interv Card Electrophysiol"},{"issue":"39","key":"ref85","doi-asserted-by":"crossref","first-page":"3948","DOI":"10.1093\/eurheartj\/ehad193","article-title":"2023 ESC Guidelines for the management of endocarditis","volume":"44","author":"V Delgado","year":"2023","journal-title":"Eur Heart J"},{"issue":"01","key":"ref86","first-page":"154","article-title":"Real-world experience with the new Watchman FLX device: data from two high-volume Sicilian centers. The FLX-iEST registry","volume":"100","author":"G Vizzari","year":"2022","journal-title":"Catheter Cardiovasc Interv"},{"issue":"21","key":"ref87","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1016\/j.jcin.2022.09.002","article-title":"Comparative safety of transcatheter LAAO with the first-generation Watchman and next-generation Watchman FLX devices","volume":"15","author":"M J Price","year":"2022","journal-title":"JACC Cardiovasc Interv"},{"issue":"06","key":"ref88","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/j.hrthm.2022.02.011","article-title":"The ALSTER-FLX registry: 3-month outcomes after left atrial appendage occlusion using a next-generation device, a matched-pair analysis to EWOLUTION","volume":"19","author":"C Paitazoglou","year":"2022","journal-title":"Heart Rhythm"},{"issue":"05","key":"ref89","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.hroo.2022.07.004","article-title":"Outcomes of the roll-in cohort of the Amulet IDE trial of left atrial appendage occlusion","volume":"3","author":"D Lakkireddy","year":"2022","journal-title":"Heart Rhythm O2"},{"issue":"04","key":"ref90","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.jjcc.2018.10.010","article-title":"Left atrial appendage occlusion using LAmbre Amulet and Watchman in atrial fibrillation","volume":"73","author":"S Chen","year":"2019","journal-title":"J Cardiol"},{"issue":"06","key":"ref91","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1093\/europace\/euaa004","article-title":"A collective European experience with left atrial appendage suture ligation using the LARIAT+ device","volume":"22","author":"R R Tilz","year":"2020","journal-title":"Europace"},{"issue":"03","key":"ref92","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1093\/europace\/euac270","article-title":"Real-world clinical outcomes with a next-generation left atrial appendage closure device: the FLXibility Post-Approval Study","volume":"25","author":"T R Betts","year":"2023","journal-title":"Europace"},{"key":"ref93","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.carrev.2022.05.017","article-title":"Review of late-breaking trials from CRT 2022","volume":"40S","author":"S Bhogal","year":"2022","journal-title":"Cardiovasc Revasc Med"},{"key":"ref94","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.carrev.2023.04.017","article-title":"Review of late-breaking trials from CRT 2023","volume":"53S","author":"I Merdler","year":"2023","journal-title":"Cardiovasc Revasc Med"},{"issue":"19","key":"ref95","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1161\/CIRCULATIONAHA.121.057063","article-title":"Amplatzer Amulet left atrial appendage occluder versus Watchman device for stroke prophylaxis (Amulet IDE): a randomized, controlled trial","volume":"144","author":"D Lakkireddy","year":"2021","journal-title":"Circulation"},{"key":"ref96","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/S0140-6736(09)61343-X","article-title":"Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial","volume":"374","author":"D R Holmes","year":"2009","journal-title":"Lancet"},{"issue":"06","key":"ref97","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1161\/CIRCULATIONAHA.112.114389","article-title":"Percutaneous left atrial appendage closure for stroke prophylaxis in patients with atrial fibrillation: 2.3-year follow-up of the PROTECT AF (Watchman Left Atrial Appendage System for Embolic Protection in Patients with Atrial Fibrillation) trial","volume":"127","author":"V Y Reddy","year":"2013","journal-title":"Circulation"},{"issue":"07","key":"ref98","doi-asserted-by":"crossref","first-page":"877","DOI":"10.4244\/EIJ-D-17-00042","article-title":"Safety and efficacy of early anticoagulation drug regimens after WATCHMAN left atrial appendage closure: three-month data from the EWOLUTION prospective, multicentre, monitored international WATCHMAN LAA closure registry","volume":"13","author":"M W Bergmann","year":"2017","journal-title":"EuroIntervention"},{"issue":"24","key":"ref99","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1136\/heartjnl-2015-309150","article-title":"Left atrial appendage occlusion in high-risk patients with non-valvular atrial fibrillation","volume":"102","author":"S Berti","year":"2016","journal-title":"Heart"},{"issue":"17","key":"ref100","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.4244\/EIJ-D-16-00726","article-title":"Transcatheter left atrial appendage occlusion in patients with atrial fibrillation and a high bleeding risk using aspirin alone for post-implant antithrombotic therapy","volume":"12","author":"K Korsholm","year":"2017","journal-title":"EuroIntervention"},{"issue":"07","key":"ref101","doi-asserted-by":"crossref","first-page":"867","DOI":"10.4244\/EIJ-D-17-00493","article-title":"Left atrial appendage occlusion with the AMPLATZER Amulet device: periprocedural and early clinical\/echocardiographic data from a global prospective observational study","volume":"13","author":"U Landmesser","year":"2017","journal-title":"EuroIntervention"},{"issue":"04","key":"ref102","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.jcin.2016.11.029","article-title":"Incidence and clinical impact of device-associated thrombus and peri-device leak following left atrial appendage closure with the Amplatzer Cardiac Plug","volume":"10","author":"J Saw","year":"2017","journal-title":"JACC Cardiovasc Interv"},{"issue":"18","key":"ref103","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1161\/CIRCULATIONAHA.120.050117","article-title":"Primary outcome evaluation of a next-generation left atrial appendage closure device: results from the PINNACLE FLX trial","volume":"143","author":"S Kar","year":"2021","journal-title":"Circulation"},{"issue":"07","key":"ref104","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1016\/j.hrthm.2021.02.022","article-title":"Left atrial appendage closure in patients with prohibitive anatomy: insights from PINNACLE FLX","volume":"18","author":"C R Ellis","year":"2021","journal-title":"Heart Rhythm"},{"issue":"13","key":"ref105","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1016\/j.jacep.2020.06.028","article-title":"The Watchman FLX device: first European experience and feasibility of intracardiac echocardiography to guide implantation","volume":"6","author":"K Korsholm","year":"2020","journal-title":"JACC Clin Electrophysiol"},{"issue":"05","key":"ref106","doi-asserted-by":"crossref","first-page":"E348","DOI":"10.25270\/jic\/21.00240","article-title":"True efficacy of LAA closure: patient outcomes on long-term single-antiplatelet or no therapy: insights from the EWOLUTION registry","volume":"34","author":"C Paitazoglou","year":"2022","journal-title":"J Invasive Cardiol"},{"issue":"04","key":"ref107","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.jacc.2021.04.098","article-title":"Predictors of device-related thrombus following percutaneous left atrial appendage occlusion","volume":"78","author":"T Simard","year":"2021","journal-title":"J Am Coll Cardiol"},{"issue":"17","key":"ref108","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1016\/j.jcin.2023.05.045","article-title":"Impact of device implant depth after left atrial appendage occlusion","volume":"16","author":"P Cepas-Guill\u00e9n","year":"2023","journal-title":"JACC Cardiovasc Interv"},{"key":"ref109","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1016\/j.jacep.2023.04.013","article-title":"Enhanced thromboresistance and endothelialization of a novel fluoropolymer-coated left atrial appendage closure device","volume":"9","author":"W I Saliba","year":"2023","journal-title":"JACC Clin Electrophysiol"},{"issue":"09","key":"ref110","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1093\/europace\/euad237","article-title":"Mechanisms, predictors, and evolution of severe peri-device leaks with two different left atrial appendage occluders","volume":"25","author":"D Lakkireddy","year":"2023","journal-title":"Europace"},{"issue":"12","key":"ref111","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1016\/j.jacep.2021.06.002","article-title":"Radiofrequency energy applications targeting significant residual leaks after Watchman implantation: a prospective, multicenter experience","volume":"7","author":"D G Della Rocca","year":"2021","journal-title":"JACC Clin Electrophysiol"},{"issue":"09","key":"ref112","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1080\/14779072.2018.1510316","article-title":"Antithrombotic strategies after interventional left atrial appendage closure: an update","volume":"16","author":"S Chen","year":"2018","journal-title":"Expert Rev Cardiovasc Ther"},{"issue":"01","key":"ref113","doi-asserted-by":"crossref","first-page":"12","DOI":"10.2459\/JCM.0000000000001394","article-title":"Impact and predictors of device-related thrombus after percutaneous left atrial appendage closure","volume":"24","author":"L Branca","year":"2023","journal-title":"J Cardiovasc Med (Hagerstown)"},{"key":"ref114","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1016\/S0140-6736(06)68845-4","article-title":"Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial","volume":"367","author":"S Connolly","year":"2006","journal-title":"Lancet"},{"issue":"09","key":"ref115","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1056\/NEJMoa1007432","article-title":"Apixaban in patients with atrial fibrillation","volume":"364","author":"S J Connolly","year":"2011","journal-title":"N Engl J Med"},{"key":"ref116","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0140-6736(07)61233-1","article-title":"Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial","volume":"370","author":"J Mant","year":"2007","journal-title":"Lancet"},{"issue":"18","key":"ref117","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1056\/NEJMoa2012883","article-title":"Low-dose edoxaban in very elderly patients with atrial fibrillation","volume":"383","author":"K Okumura","year":"2020","journal-title":"N Engl J Med"},{"issue":"04","key":"ref118","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.31083\/j.rcm2204128","article-title":"Clinical and multi-modality imaging approach in the selection of patients for left atrial appendage closure","volume":"22","author":"L Riegler","year":"2021","journal-title":"Rev Cardiovasc Med"},{"issue":"11","key":"ref119","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/j.jcin.2019.04.004","article-title":"Propensity-matched comparison of oral anticoagulation versus antiplatelet therapy after left atrial appendage closure with WATCHMAN","volume":"12","author":"L S\u00f8ndergaard","year":"2019","journal-title":"JACC Cardiovasc Interv"},{"issue":"03","key":"ref120","doi-asserted-by":"crossref","first-page":"255","DOI":"10.33963\/KP.15864","article-title":"Percutaneous left atrial appendage occlusion in the current practice","volume":"79","author":"I Cruz-Gonz\u00e1lez","year":"2021","journal-title":"Kardiol Pol"},{"issue":"07","key":"ref121","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1093\/europace\/euaa074","article-title":"Initial and long-term antithrombotic therapy after left atrial appendage closure with the WATCHMAN","volume":"22","author":"J Ledwoch","year":"2020","journal-title":"Europace"},{"issue":"18","key":"ref122","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1016\/j.jacc.2022.02.047","article-title":"Antithrombotic therapy after left atrial appendage occlusion in patients with atrial fibrillation","volume":"79","author":"J V Freeman","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"ref123","doi-asserted-by":"crossref","first-page":"S36","DOI":"10.1016\/j.hrthm.2023.03.272","article-title":"Ce-452771\u20134 outcomes with different postprocedural antithrombotic therapy regimens following left atrial appendage occlusion","volume":"20","author":"J Freeman","year":"2023","journal-title":"Heart Rhythm"},{"issue":"18","key":"ref124","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1016\/j.jacc.2023.08.010","article-title":"Comparison of initial antithrombotic regimens after left atrial appendage occlusion: a systematic review and network meta-analysis","volume":"82","author":"P EP Carvalho","year":"2023","journal-title":"J Am Coll Cardiol"},{"issue":"09","key":"ref125","doi-asserted-by":"crossref","first-page":"101269","DOI":"10.1016\/j.cpcardiol.2022.101269","article-title":"Single versus dual antiplatelet therapy following left atrial appendage occlusion in patients with high bleeding risk","volume":"47","author":"M Mhanna","year":"2022","journal-title":"Curr Probl Cardiol"},{"key":"ref126","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.ijcard.2022.09.066","article-title":"Looking for optimal antithrombotic strategy after transcatheter left atrial appendage occlusion: a real-world comparison of different antiplatelet regimens","volume":"371","author":"L Vignali","year":"2023","journal-title":"Int J Cardiol"},{"issue":"17","key":"ref127","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1016\/j.jacc.2016.08.016","article-title":"Single antiplatelet therapy following left atrial appendage closure in patients with contraindication to anticoagulation","volume":"68","author":"T Rodriguez-Gabella","year":"2016","journal-title":"J Am Coll Cardiol"},{"issue":"11","key":"ref129","first-page":"8","article-title":"Low dose of direct oral anticoagulants after left atrial appendage occlusion","volume":"8","author":"P L Cepas-Guillen","year":"2021","journal-title":"J Cardiovasc Dev Dis"},{"issue":"21","key":"ref130","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.1016\/j.jcin.2021.07.031","article-title":"Half-dose direct oral anticoagulation versus standard antithrombotic therapy after left atrial appendage occlusion","volume":"14","author":"D G Della Rocca","year":"2021","journal-title":"JACC Cardiovasc Interv"},{"issue":"01","key":"ref134","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.jacep.2022.07.014","article-title":"Incidence, predictors, and clinical outcomes of device-related thrombus in the Amulet IDE trial","volume":"9","author":"B Schmidt","year":"2023","journal-title":"JACC Clin Electrophysiol"},{"issue":"09","key":"ref135","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1161\/CIRCULATIONAHA.118.035090","article-title":"Device-related thrombus after left atrial appendage closure: incidence, predictors, and outcomes","volume":"138","author":"S R Dukkipati","year":"2018","journal-title":"Circulation"},{"issue":"05","key":"ref136","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.jacc.2022.04.062","article-title":"Impact of peridevice leak on 5-year outcomes after left atrial appendage closure","volume":"80","author":"S R Dukkipati","year":"2022","journal-title":"J Am Coll Cardiol"},{"issue":"06","key":"ref137","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/j.jacep.2022.03.001","article-title":"Clinical impact of residual leaks following left atrial appendage occlusion: insights from the NCDR LAAO registry","volume":"8","author":"M Alkhouli","year":"2022","journal-title":"JACC Clin Electrophysiol"},{"issue":"18","key":"ref138","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1016\/j.jacc.2019.08.1045","article-title":"Direct current cardioversion of atrial fibrillation in patients with left atrial appendage occlusion devices","volume":"74","author":"S P Sharma","year":"2019","journal-title":"J Am Coll Cardiol"},{"issue":"03","key":"ref139","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1111\/jce.14889","article-title":"Impact of anticoagulation strategy after left atrial appendage occlusion in patients requiring direct current cardioversion","volume":"32","author":"M Maarse","year":"2021","journal-title":"J Cardiovasc Electrophysiol"},{"issue":"01","key":"ref140","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1161\/CIR.0000000000001193","article-title":"ACC\/AHA\/ACCP\/HRS guideline for the diagnosis and management of atrial fibrillation: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"149","author":"J A Joglar","year":"2024","journal-title":"Circulation"}],"container-title":["Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/a-2469-4896.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,22]],"date-time":"2025-08-22T22:36:42Z","timestamp":1755902202000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/a-2469-4896"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,10]]},"references-count":118,"journal-issue":{"issue":"09","published-online":{"date-parts":[[2025,8,22]]},"published-print":{"date-parts":[[2025,9]]}},"URL":"https:\/\/doi.org\/10.1055\/a-2469-4896","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["0340-6245","2567-689X"],"issn-type":[{"value":"0340-6245","type":"print"},{"value":"2567-689X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,10]]}}}